Medical Oncology Associates, PS

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Lung cancer2 trials
• Pancreatic cancer2 trials
• Chronic lymphocytic leukaemia1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Melanoma1 trial
• Multiple myeloma1 trial
• Ovarian cancer1 trial

Phase

• Phase 34 trials
• Phase 1/21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Amgen3 trials
• Celgene1 trial
• Genmab1 trial
• Loxo Oncology, Inc.1 trial

Running trials

• Recruiting

  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  NCT05254743· Phase 3· Loxo Oncology, Inc.· Source

  Contact: Arvind Chaudhry (principal investigator)

• Active, not recruiting

  Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

  NCT03937154· Phase 3· Amgen· Source

• Active, not recruiting

  GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

  NCT04083599· Phase 1/2· Genmab· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia1 recruiting

Closed trials

• Completed

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· Phase 3· Amgen· Source

• Completed

  Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

  NCT03362177· Phase 3· Amgen· Source

• Terminated

  Connect® MM- The Multiple Myeloma Disease Registry

  NCT01081028· Celgene· Source